QPHENZI

Serial Number 98355310
731

Registration Progress

Application Filed
Jan 12, 2024
Under Examination
Feb 4, 2025
Approved for Publication
Dec 10, 2024
Published for Opposition
Dec 10, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Aug 04, 2026 175 days

Trademark Image

QPHENZI

Basic Information

Serial Number
98355310
Filing Date
January 12, 2024
Published for Opposition
December 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Dec 16, 2025
Application
Pending
Classes
005

Rights Holder

HIKMA PHARMACEUTICALS USA INC.

03
Address
200 CONNELL DR., 4TH FLOOR
BERKELEY HEIGHTS, NJ 07922

Ownership History

Xellia Pharmaceuticals ApS

Original Applicant
16
Copenhagen S DK

Xellia Pharmaceuticals ApS

Owner at Publication
16
Copenhagen S DK

HIKMA PHARMACEUTICALS USA INC.

New Owner After Publication #1
03
BERKELEY HEIGHTS, NJ

Legal Representation

Attorney
MICHELLE TOCHTROP

USPTO Deadlines

Next Deadline
175 days remaining
NOA E-Mailed - SOU Required
Due Date
August 04, 2026
Extension Available
Until February 04, 2027

Application History

30 events
Date Code Type Description Documents
Dec 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 16, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 16, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 14, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 14, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 12, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Feb 4, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 15, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 15, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 15, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 15, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 15, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 15, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 15, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 15, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 14, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 14, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 14, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 14, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 14, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 14, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 8, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 6, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of hypotension; pharmaceutical preparation in the nature of vasopressors for treatment of shock to raise blood pressure; pharmaceutical injectable preparations for increasing systolic blood pressure, diastolic blood pressure, mean arterial pressure and total peripheral vascular resistance; decongestant and vasoconstrictor preparation; phenylephrine pharmaceutical injectable preparation for use as a decongestant and vasoconstrictor

Classification

International Classes
005